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India witnessed a major transition in 2013. It marked the
completion of 50 years of the activities of the Indian Acad-
emy of Pediatrics, the completion of a taskforce study
conducted by ICMR, organization of the Asia Pacific
meeting on newborn screening and inclusion of congenital
hypothyroidism as an important activity of a landmark
program by the Government, the Rashtriya Bal Suraksha
Kayakram. It has also created a platform for inclusion of
many Delhi Hospitals in newborn screening.
These activities have created 3 major thrust points in the
country which include awareness about the need for
screening, the feasibility of its execution in the metropoli-
tan cities of our country and the commitment to make
the special diets available. Both public and private players
have developed deep commitments which are likely to
change the face of newborn screening in the country.
Screening for 5 nearly completely reversible and treatable
disorders is possible. These include Congenital Hypothyr-
oidism, Congenital Adrenal Hyperplasia, Glucose-6-phos-
phate dehydrogenase deficiency, Biotinidase deficiency and
Galactosemia. These have been included in different pilot
programs across India.
Challenges which invite discussion are the feasibility of
coverage in less well developed areas, hilly terrains and the
home deliveries. MCTS (Mother child tracking system) an
initiative launched by the Government of India once in
full implementation may play a pivotal role in this pro-
gram. Availability of good counselors and a well integrated
follow up system needs to be developed so that all screen
positive babies can be followed up. Generation of epide-
miologic data for the currently untreatable conditions
being the non availability of diets needs to be simulta-
neously addressed so that we can gear up for the expanded
phase later.
Generating ethnic cutoffs, ensuring quality compli-
ance, improving availability of confirmatory tests needs
to be addressed. The volumes are formidable but also
suggest that with high rates of consanguinity and
inbreeding one is likely to encounter a significant propor-
tion of these in the country. The most positive aspect is
the commitment to this noble cause which will help us
cross and reach the horizon.
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